599-33-7

Basic information

• Product Name: prednylidene
• Synonyms: prednylidene;16-methyleneprednisolone;11β,17,21-Trihydroxy-16-methylenepregna-1,4-diene-3,20-dione
• CAS NO: 599-33-7
• Molecular Formula: C₂₂H₂₈O₅
• Molecular Weight: 372.45
• EINECS: 209-964-9
• Mol File: 599-33-7.mol
• Article Data: 1

Chemical Properties

• Melting Point: 233-235°
• Boiling Point: 581.1°Cat760mmHg
• Flash Point: 319.3°C
• Appearance: /
• Density: 1.3g/cm³
• Refractive Index: 1.613
• CAS DataBase Reference: prednylidene(CAS DataBase Reference)
• NIST Chemistry Reference: prednylidene(599-33-7)
• EPA Substance Registry System: prednylidene(599-33-7)

Safety Data

• Hazardous Substances Data: 599-33-7(Hazardous Substances Data)

Usage

Description

Prednylidene is a synthetic corticosteroid characterized by its anti-inflammatory and immunosuppressive properties. It is a derivative of prednisolone, known for its efficacy in treating a range of conditions including arthritis, allergies, and specific skin disorders. Prednylidene operates by curbing the production of inflammatory mediators and dampening the immune response, making it a valuable asset in managing inflammation.

Uses

Used in Pharmaceutical Industry:
Prednylidene is used as an anti-inflammatory agent for its ability to mitigate inflammation and alleviate symptoms associated with various conditions such as arthritis, allergies, and skin disorders. Its mechanism of action involves the inhibition of inflammatory mediator production and suppression of the immune response, which is beneficial in managing the severity of these conditions.
Used in Dermatological Applications:
In the dermatological field, prednylidene is used as a topical treatment in the form of creams or ointments. It is applied directly to the skin to treat certain skin conditions, leveraging its anti-inflammatory properties to reduce redness, swelling, and itching.
Used in Oral Medication:
Prednylidene is also utilized in oral forms such as tablets or capsules for systemic administration. This allows for the treatment of conditions that require a broader anti-inflammatory effect, extending its benefits beyond localized applications.

InChI:InChI=1/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,15-17,19,23,25,27H,1,4-5,8,10-11H2,2-3H3/t15-,16-,17-,19+,20-,21-,22-/m0/s1

Relevant articles and documents

Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor

Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.